UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies Journal article
Tang, Zheng-Hai, Lu, Jin-Jian. Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies[J]. CANCER LETTERS, 2018, 420, 242-246.
Authors:  Tang, Zheng-Hai;  Lu, Jin-Jian
Favorite | TC[WOS]:100 TC[Scopus]:109  IF:9.1/8.3 | Submit date:2018/10/30
Osimertinib  Azd9291  Egfr Tki  Resistant Mechanisms  Therapeutic Strategies  
Increased expression of IRE1α associates with the resistant mechanism of osimertinib (AZD9291)-resistant non-small cell lung cancer HCC827/OSIR cells Journal article
Zheng-hai Tang, Min-Xia Su, Xia Guo, Xiao-Ming Jiang, Lin Jia, Xiuping Chen, Jin-Jian Lu. Increased expression of IRE1α associates with the resistant mechanism of osimertinib (AZD9291)-resistant non-small cell lung cancer HCC827/OSIR cells[J]. Anti-Cancer Agents in Medicinal Chemistry, 2018, 18(4), 550-555.
Authors:  Zheng-hai Tang;  Min-Xia Su;  Xia Guo;  Xiao-Ming Jiang;  Lin Jia; et al.
Favorite | TC[WOS]:0 TC[Scopus]:18 | Submit date:2018/12/28
Azd9291  Egfr  Ire1α  Lune Cancer  Nsclc  Osimertinib  
Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells Journal article
Tang, Zheng-Hai, Cao, Wen-Xiang, Su, Min-Xia, Chen, Xiuping, Lu, Jin-Jian. Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 321, 18-26.
Authors:  Tang, Zheng-Hai;  Cao, Wen-Xiang;  Su, Min-Xia;  Chen, Xiuping;  Lu, Jin-Jian
Favorite | TC[WOS]:53 TC[Scopus]:54  IF:3.3/3.6 | Submit date:2018/10/30
Osimertinib  Azd9291  Autophagy  Apoptosis  Ros  
Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells Conference paper
Tang, ZH, Su, MX, Cao, WX, Chen, X. P., Lu, J.. Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells[C], 2016.
Authors:  Tang, ZH;  Su, MX;  Cao, WX;  Chen, X. P.;  Lu, J.
Favorite |  | Submit date:2022/08/26
Osimertinib  AZD9291  autophagy  apoptosis  NSCLC  
Treatment of osimertinib (AZD9291)-resistant non-small cell lung cancer HCC827/OSIR cells by targeting inositol-requiring enzyme 1α Conference paper
Tang, ZH, Su, MX, Guo, XH, Jiang, XM, Chen, X. P., Lu, J.. Treatment of osimertinib (AZD9291)-resistant non-small cell lung cancer HCC827/OSIR cells by targeting inositol-requiring enzyme 1α[C], 2016.
Authors:  Tang, ZH;  Su, MX;  Guo, XH;  Jiang, XM;  Chen, X. P.; et al.
Favorite |  | Submit date:2022/08/26
osimertinib  AZD9291  EGFR  IRE1α  NSCLC  
Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line Journal article
Zheng-Hai Tang, Xiao-Ming Jiang, Xia Guo, Chi Man Vivienne Fong, Xiuping Chen, Jin-Jian Lu. Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line[J]. Oncotarget, 2016, 7(49), 81598-81610.
Authors:  Zheng-Hai Tang;  Xiao-Ming Jiang;  Xia Guo;  Chi Man Vivienne Fong;  Xiuping Chen; et al.
Favorite | TC[WOS]:42 TC[Scopus]:43 | Submit date:2018/12/28
Azd9291  Egfr  Navitoclax  Nsclc  Osimertinib